Stay updated on E2609 Dose-Finding in Alzheimer's Disease Clinical Trial
Sign up to get notified when there's something new on the E2609 Dose-Finding in Alzheimer's Disease Clinical Trial page.

Latest updates to the E2609 Dose-Finding in Alzheimer's Disease Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now shows revision v3.4.2 replacing v3.4.1, with no impact on core study details, eligibility criteria, results, or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1, indicating a minor page update.SummaryDifference0.0%

- Check33 days agoChange DetectedShow glossary / Hide glossary toggle added. Capitalization changes for labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' were implemented, and the revision label updated to v3.4.0 (from v3.3.4).SummaryDifference0.3%

- Check40 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no other page content or functionality appears to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded a dedicated Locations section listing participating states (CA, FL, GA, KS, MI, NJ, NC, OH, SC, TX) and updated the study record to revision v3.3.3.SummaryDifference1.0%

- Check91 days agoChange DetectedThe page shows a version upgrade from v3.2.0 to v3.3.2 with UI improvements; study details, eligibility criteria, and locations appear unchanged.SummaryDifference0.0%

Stay in the know with updates to E2609 Dose-Finding in Alzheimer's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the E2609 Dose-Finding in Alzheimer's Disease Clinical Trial page.